• Cellvizio®
    • Overview
    • Education
    • Economics
    • Indications
      • Gastroenterology
        • Barrett’s Esophagus
        • Pancreatic Cysts
        • Gastric Disease
        • Inflammatory Bowel Diseases
        • Irritable Bowel Syndrome – Food Intolerance
        • Bilio-Pancreatic Strictures
        • Colorectal Lesions
      • Pulmonology
        • Lung Nodules
        • Lung Transplant
      • Urology
  • Investors
    • Overview
    • Events and Presentations
    • Financials
    • Governance
  • About Us
    • Our Story
    • Team
      • Board of Directors
      • Leadership Team
    • Join Us
    • Commercial Network
  • Newsroom
    • News
    • Events
    • Press Coverage
  • US
    • INT
    • FR
Mauna Kea Technologies reports fourth quarter and full year 2020 sales

Mauna Kea Technologies reports fourth quarter and full year 2020 sales

by Zina | Jan 21, 2021 | News

 Fourth quarter total sales increased 41% year-over-year; U.S. sales up 44%  Full year sales decreased 12% year-over-year; U.S. sales up 4% year-over-year  2H’20 total sales up 27% year-over-year READ THE COMPLETE PRESS...
Mauna Kea Technologies reports fourth quarter and full year 2020 sales

Mauna Kea Technologies Announces its 2021 Financial Calendar

by Zina | Jan 11, 2021 | News

READ THE COMPLETE PRESS RELEASE
Mauna Kea Technologies reports fourth quarter and full year 2020 sales

Mauna Kea Technologies reports preliminary fourth quarter 2020 sales

by Zina | Jan 6, 2021 | News

Preliminary Fourth Quarter Total Sales Increase 30% to 36% year-over-year; U.S. Sales up 34% to 38% year-over-year and up 20% to 23% quarter-over-quarter.   Mauna Kea Technologies today announced preliminary sales for the fourth quarter of 2020. Given...
Mauna Kea Technologies reports fourth quarter and full year 2020 sales

Mauna Kea Technologies to Participate at Three Upcoming Investor Conferences in January

by Zina | Jan 5, 2021 | News

Mauna Kea Technologies today announced that management will participate in the following upcoming investor conferences in January:  The Oddo-BHF Forum, where management will host virtual one-on-one meetings on January 7th – 8th and January 11th –...
Mauna Kea Technologies reports fourth quarter and full year 2020 sales

Mauna Kea Technologies welcomes Jacquelien ten Dam to Board of Directors

by Zina | Dec 17, 2020 | News

Mauna Kea Technologies announced today the cooptation by the Board of Ms. Jacquelien ten Dam as an Independent Director, effective immediately. Ms. ten Dam replaces Dr. Jennifer Tseng, who tendered her resignation from the Board after 3 years of service. This...
« Older Entries
Next Entries »

Articles récents

  • Mauna Kea Technologies Announces Largest Annual Pancreatic Cyst Consortium at Digestive Disease Week® 2025 
  • Publication of the 2024 Annual Financial Report 
  • Digestive Disease Week 2025
  • Mauna Kea Technologies Announces Another Milestone Year at Digestive Disease Week® 2025 with 8 Presentations Demonstrating the Clinical Value of Cellvizio® in Key Indications 
  • Mauna Kea Technologies Reports Full Year 2024 Results and Provides a Business Update 

Commentaires récents

No comments to show.

Company Info

About Us

Join Us

Contact Us

Legal

Legal notice

Privacy policy

Our websites

Cellvizio.net

cell-tolerance.com

Diagnosingbarretts.org

Diagnosingpancreaticcysts.org

Follow us

  • Follow
  • Follow
  • Follow
  • Follow
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}